AC Immune says number of families affected by Alzheimer’s could nearly triple by 2050

Ken BellLTC News

Reuters (11/07/2021) – FRANKFURT, Nov 7 (Reuters) – Alzheimer's drug developer AC Immune (ACIU.O) expects the number of families to be affected by the degenerative disease could nearly triple by 2050 to 150 million, its CEO said in an interview with a German magazine. Full story »